Overview

Tech Summary

Promoter Holding

Posts

GLAND

901234567893012345678920123456789.4012345678950123456789
+8.40 (+0.91%)
The current prices are delayed.Login/Sign Up to see live prices.
Previous Close: 924.05
1D
5D
1M
3M
1Y
5Y
MAX
Today's low
921.25
Today's high
943
52 week low
861
52 week high
1477.85
Volume
336810
About
Tech Summary
DMA(12)
โ‚น2697.85
DMA(50)
โ‚น2979.35
DMA(100)
โ‚น3158.54
DMA(200)
โ‚น3447.77
Fund Summary
Market Cap
โ‚น15357.45 Cr.
Enterprise Value
โ‚น12267.94 Cr.
No. of Shares
16.47
P/E
19.66
RoE
18.61
Debt/Equity
0
Valuations
PE Chart
2025303540
PB Chart
2.03.04.05.0
Promoter Holdings
Public : 14.58%
FII : 4.32%
DII : 23.24%
Promoter : 57.86%
Others : 0%
Charts
โฎ
โฏ
Debt/Equity
0
Mar, 2020Mar, 2021Mar, 2022
ROE vs ROCE
18202224262830
Mar, 2020Mar, 2021Mar, 2022
ROE
ROCE
Revenue vs Profitability (1000Cr.)
1.02.03.04.0
Mar, 2020Mar, 2021Mar, 2022
Revenue
Profit
Margins(%)
2530354045
Mar, 2020Mar, 2021Mar, 2022
Net Margin
Gross Margin
About
Hero Img
Create your account on Frontpage
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Stock Sentiments
98% Bullish
2% Bearish
114 live trades of Rs. 11,596,859.65
N
nirav-BkuOe7X5j
ย 
Reputation: 0ย โ€ขย 
Today 7:15 PM
GLAND
100 Qty (S) Trade entered-โ‚น80
N
noorulhaque786
ย 
Reputation: 16ย โ€ขย 
Today 6:17 PM
GLAND
25 Qty (S) Trade entered-โ‚น70
Posts by FrontPage Users
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย May 24 11:28 PM
Gland Pharmaโ€™s prospects after dismal earnings fail to impress investors
Gland Pharmaโ€™s prospects after dismal earnings fail to impress investors
Analysts are also concerned about the lack of optimism in the management's commentary on margins improving.
Moneycontrol
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย May 23 5:23 PM
Gland Pharma shares rebound with 10% rally after 5-day losing streak
Gland Pharma shares rebound with 10% rally after 5-day losing streak
Gland Pharma's rebound comes after the stock had lost close to 39 percent in the past five sessions.
Moneycontrol
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย May 23 4:48 AM
Bulk deals | Porinju Veliyath's firm picks 0.53% stake in Kokuyo Camlin; GQG Partners buys Rs 415 crore shares in Max Healthcare
Bulk deals | Porinju Veliyath's firm picks 0.53% stake in Kokuyo Camlin; GQG Partners buys Rs 415 crore shares in Max Healthcare
Kokuyo Camlin shares rallied more than 14 percent to Rs 110.50 with significantly higher volumes on the NSE.
Moneycontrol
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย May 19 3:53 PM
Gland Pharma plunges to 52-week low as Q4 net profit slumps 72.5%, revenue drops 29%
Gland Pharma plunges to 52-week low as Q4 net profit slumps 72.5%, revenue drops 29%
The drugmaker's net profit for the quarter plummeted to Rs 78.6 crore due to high base on account of COVID sales and a shutdown of production line in the Pashamylaram Penems facility for line upgradation.
Moneycontrol
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย May 19 3:38 AM
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย May 19 1:03 AM
Add a comment
Navneet Singh-display-image
Reputation: 1,594ย ย โ€ขย ย May 5 9:06 PM

GLAND PHARMA LTD. (risky trade, just observe)
entry activated.
Chartbusters - chart - 57634801
Comment
Share
Add a comment
Soniindex-display-image
Reputation: 8,490ย ย โ€ขย ย Feb 22 2:38 AM
Comment
Share
Add a comment
Ritesh Patil -display-image
Reputation: 0ย ย โ€ขย ย Feb 2 12:53 AM
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย Jan 25 11:08 PM
Buy Gland Pharma; target of Rs 1720: YES Securities
Buy Gland Pharma; target of Rs 1720: YES Securities
YES Securities is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 1720 in its research report dated January 23, 2023.
Moneycontrol
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย Jan 25 3:48 AM
Buy Gland Pharma; target of Rs 1700: Motilal Oswal
Buy Gland Pharma; target of Rs 1700: Motilal Oswal
Motilal Oswal is bullish on Gland Pharma recommended buy rating on the stock with a target price of Rs 1700 in its research report dated January 23, 2023.
Moneycontrol
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย Jan 24 2:53 PM
Gland Pharma profit declines 15% in Q3: What should you do with the stock?
Gland Pharma profit declines 15% in Q3: What should you do with the stock?
Gland Pharma Q3: Revenue from operations for the quarter at Rs 938 crore declined 12% compared to year-ago period.
Moneycontrol
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย Jan 24 4:43 AM
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย Jan 24 4:28 AM
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย Jan 17 7:53 PM
Gland Pharma Q3 PAT to Rs 2,729 cr: Nirmal Bang
Gland Pharma Q3 PAT to Rs 2,729 cr: Nirmal Bang
Net Sales are expected to increase by 0.6 percent Y-o-Y (up 2.4 percent Q-o-Q) to Rs 10,696 crore, according to Nirmal Bang.
Moneycontrol
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย Dec 30, 2022 9:08 PM
Hold Gland Pharma; target of Rs 1689: Sharekhan
Hold Gland Pharma; target of Rs 1689: Sharekhan
Sharekhan recommended Hold rating on Gland Pharma with a target price of Rs 1689 in its research report dated December 29, 2022.
Moneycontrol
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย Dec 23, 2022 11:33 PM
Gland, Cipla, Sun Pharma top picks; too soon to decipher new COVID opportunity: Sanford Bernstein's Nithya Balasubramanian
Gland, Cipla, Sun Pharma top picks; too soon to decipher new COVID opportunity: Sanford Bernstein's Nithya Balasubramanian
China is a very different economy and its vaccination coverage is lower while infection rate is higher than India's, says Balasubramanian
Moneycontrol
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย Dec 13, 2022 3:08 PM
Fosun knocks on doors of Advent Intl, Baring PE, Bain Capital for Gland Pharma buyout: Report
Fosun knocks on doors of Advent Intl, Baring PE, Bain Capital for Gland Pharma buyout: Report
As per BSE filing, Fosun International has a controlling stake of 57.86 percent in Hyderabad-based Gland Pharma
Moneycontrol
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย Dec 1, 2022 6:13 PM
Buy Gland Pharma; target of Rs 2260: Sharekhan
Buy Gland Pharma; target of Rs 2260: Sharekhan
Sharekhan is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 2260 in its research report dated November 30, 2022.
Moneycontrol
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย Nov 30, 2022 9:18 PM
Analysts largely neutral on Gland Pharmaโ€™s acquisition of Cenexi Group
Analysts largely neutral on Gland Pharmaโ€™s acquisition of Cenexi Group
Gland Pharmaโ€™s management expects to close the transaction by February/March 2023 and to fund the deal through internal accruals
Moneycontrol
Comment
Share
Add a comment
Kewat Ajay-display-image
Reputation: 1,150ย ย โ€ขย ย Nov 15, 2022 3:29 AM

Study Analysis: A good Pharma stock is at make or break turning point. #GLAND . #Pharma stock. If this holds 1700 level a good upside move is expected... let's see how good this analysis works...
Chartbusters - chart - 15973618
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย Oct 31, 2022 4:53 PM
Gland Pharma sinks on fears of distress sale by Chinese owner
Gland Pharma sinks on fears of distress sale by Chinese owner
Gland Pharmaโ€™s earnings for the September quarter have also done little to ease investorsโ€™ anxiety given that the company reported a sharp decline in net profit
Moneycontrol
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย Oct 28, 2022 10:53 PM
Buy Gland Pharma; target of Rs 2260: Sharekhan
Buy Gland Pharma; target of Rs 2260: Sharekhan
Sharekhan is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 2260 in its research report dated October 27, 2022.
Moneycontrol
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย Oct 27, 2022 3:58 PM
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย Oct 27, 2022 3:33 PM
Add a comment
Valid CHARTS -display-image
Reputation: 14,929ย ย โ€ขย ย Oct 8, 2022 3:14 PM

Jab list huya vaha se double ho gya aur fr vapis vaha aa gya๐Ÿ˜‚
Timeframe - weekly
Chartbusters - chart - 13645462
2 Comments
Share
Add a comment
Ankit-display-image
Reputation: 3,152ย ย โ€ขย ย Sep 28, 2022 12:42 AM
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย Sep 2, 2022 12:23 PM
Trade Spotlight | What should you do with ABB India, Gland Pharma, Schneider Electric Infra on Friday?
Trade Spotlight | What should you do with ABB India, Gland Pharma, Schneider Electric Infra on Friday?
Gland Pharma jumped 5.6 percent to Rs 2,501 and formed small bodied bullish candle on the daily scale, while Schneider Electric Infrastructure climbed over 6 percent to Rs 145.3 and Inverted Hammer kind of pattern on the daily charts with above average volumes.
Moneycontrol
Comment
Share
Add a comment
Wealth Mentors-display-image
Reputation: 1,526ย ย โ€ขย ย Sep 1, 2022 8:18 PM

BTST
GLAND
Cmp: 2511
TGT: 2540- 2580- 2700
Sl: 2460
Cash
Comment
Share
Add a comment
MediTrading-display-image
Reputation: 742ย ย โ€ขย ย Aug 25, 2022 7:52 PM

#GLAND GLAND PHARMA - readying for some decent up moves. All levels mentioned on the chart.
Chartbusters - chart - 11882531
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย Jul 22, 2022 3:03 AM
Buy Gland Pharma; target of Rs 3080: Sharekhan
Buy Gland Pharma; target of Rs 3080: Sharekhan
Sharekhan is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 3080 in its research report dated July 20, 2022.
Moneycontrol
Comment
Share
Add a comment
Revanth Chalamala-display-image
Reputation: 16,985ย ย โ€ขย ย Jul 21, 2022 2:17 PM
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย Jul 21, 2022 12:28 AM
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย Jul 21, 2022 12:28 AM
Add a comment
ResultsBot-display-image
Reputation: 20,317ย ย โ€ขย ย Jul 19, 2022 12:30 AM

#GLAND will declare results on Jul 20, 2022
Please plan your trades accordingly ๐Ÿ˜Ž
Comment
Share
Add a comment
morninghaze-display-image
Reputation: 4,108ย ย โ€ขย ย Jul 13, 2022 4:18 PM

#GLAND Gland falling below 52 week low -- my own belief that stock fall closes below 2350, stock will be decimated --stock is long term underperformer(DYOR)(paper trading)
text_snippet
stock charts.docx
164 KB
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย Jun 27, 2022 8:03 PM
Buy Gland Pharma; target of Rs 3700: Motilal Oswal
Buy Gland Pharma; target of Rs 3700: Motilal Oswal
Motilal Oswal is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 3700 in its research report dated June 25, 2022.
Moneycontrol
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย Jun 21, 2022 4:13 PM
Gland Pharma surges as CLSA India initiates coverage with buy rating
Gland Pharma surges as CLSA India initiates coverage with buy rating
The brokerage firm expects Gland Pharma to deliver 15-20 percent growth in revenues over the next three years
Moneycontrol
Comment
Share
Add a comment
W
Reputation: 1,133ย ย โ€ขย ย Jun 17, 2022 6:59 PM

GLAND PHARMA : RS 129.53CR NSE BLOCK TRADE; FOR ~500102 SHARES, AT RS 2590
block deal #GLAND
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย May 22, 2022 2:08 AM
Buy Gland Pharma: target of Rs 3770: Sharekhan
Buy Gland Pharma: target of Rs 3770: Sharekhan
Sharekhan is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 3770 in its research report dated May 20, 2022.
Moneycontrol
Comment
Share
Add a comment
TradeAdda-display-image
Reputation: 60,200ย ย โ€ขย ย May 20, 2022 2:07 PM

*Stocks in News*
Equitas Small Finance Bank: Veteran banker P N Vasudevan has resigned as the managing director and chief executive officer of Equitas Small Finance Bank, the lender informed the stock exchanges. Vasudevan, in his resignation letter, said he wants to devote his ti......read more
Comment
Share
Add a comment
Kishore kumar Ganta -display-image
Reputation: 4,740ย ย โ€ขย ย May 20, 2022 1:02 PM

Good News :
1. Zydus lifescience going to buyback shares
2. HPCL profit rise 106%
3. Gland Pharma profit rise 9.8%
4. Ashok Leyland profit rise 273%
5. GMM Pfaudler going to give bonus
Chemical, Finance, Pharma and Textile s......read more
4 Comments
Share
Add a comment
BankNifty Expert-display-image
Reputation: 56,046ย ย โ€ขย ย May 20, 2022 3:03 AM

Gland Pharma March 2022 (Quarterly) PAT at Rs 286 crore VS Rs 260 crore YOY. Revenue at Rs 1103 crore VS Rs 888 crore YOY..
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย May 19, 2022 10:53 PM
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย May 19, 2022 10:33 PM
Add a comment
ResultsBot-display-image
Reputation: 20,317ย ย โ€ขย ย May 18, 2022 12:30 AM

#GLAND will declare results on May 19, 2022
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 42,703ย ย โ€ขย ย Apr 22, 2022 4:48 AM
Bulk deals | Menu exits Barbeque Nation, Nicomac Machinery cuts stake in Gland Pharma
Bulk deals | Menu exits Barbeque Nation, Nicomac Machinery cuts stake in Gland Pharma
Menu Private Limited sold all its 5,05,504 equity shares in Barbeque at an average price of Rs 1,163 apiece. The stock on April 21 rose 1.4 percent to Rs 1,178.
Moneycontrol
Comment
Share
Add a comment
StocksnMore-display-image
Reputation: 1,032ย ย โ€ขย ย Apr 21, 2022 7:07 PM
StocksnMore in GLAND
#GLAND
Comment
Share
Add a comment
EqmOptiontrading-display-image
Reputation: 828ย ย โ€ขย ย Apr 21, 2022 2:30 PM

STOCKS in ACTION 21 Apr

Ajanta Soya Ltd board approves stock split

Dhanvarsha Finvest allots 13,00,989 equity shares on conversion of warrants

Dr. Reddy's Laboratories announces the launch of Posaconazole Delayed-Release Tablets in the U.S. Market

Nykaa : Aveda partners with......read more
Comment
Share
Add a comment
StocksnMore-display-image
Reputation: 1,032ย ย โ€ขย ย Apr 21, 2022 2:01 PM
Comment
Share
Add a comment
Load More Posts